{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:08:56Z","timestamp":1771484936030,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.atherosclerosis.2010.06.026","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:24:51Z","timestamp":1277079891000},"page":"636-643","source":"Crossref","is-referenced-by-count":39,"title":["A comparative study of biomarkers for risk prediction in acute coronary syndrome\u2014Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study"],"prefix":"10.1016","volume":"212","author":[{"given":"Juan Carlos","family":"Kaski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Fern\u00e1ndez-Berg\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Consuegra-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M. Cruz","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Garc\u00eda-Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Mostaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo Toro","family":"Cebada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n Gonz\u00e1lez","family":"Juanatey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Guzm\u00e1n","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Marrugat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM200001133420207","article-title":"Unstable angina pectoris","volume":"342","author":"Yeghiazarians","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antmann","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/heart.87.3.201","article-title":"Inflammation in acute coronary syndromes","volume":"87","author":"Mulvihill","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindalh","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-terminal pro brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"De Lemos","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib10","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000145166.44942.E0","article-title":"Cystatin C\u2014a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome","volume":"110","author":"Jernberg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non ST segment elevation myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)","volume":"36","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","article-title":"Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"23","author":"Bertrand","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib13","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(01)01702-8","article-title":"American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)","volume":"38","author":"Cannon","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurheartj\/ehi002","article-title":"Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort","volume":"26","author":"Terkelsen","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/euhj.2002.3193","article-title":"A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)","volume":"23","author":"Hasdai","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib16","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/01.CIR.0000012625.02748.62","article-title":"Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients","volume":"105","author":"Mueller","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11 A substudy. Thrombolysis in Myocardial Infarction","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib18","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/01.CIR.100.19.1958","article-title":"Independent prognostic value of elevated C-reactive protein in unstable angina","volume":"100","author":"Ferreiros","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib19","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators, C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib21","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.106.652081","article-title":"The inflammatory hypothesis. Any progress in risk stratification and therapeutic targets?","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.96.4.1102","article-title":"Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"96","author":"Folsom","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib23","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib24","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archinte.166.13.1368","article-title":"An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study","volume":"166","author":"Folsom","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/clc.4960231016","article-title":"Transient increase in plasma brain (B-Type) natriuretic peptide after percutaneous transluminal coronary angioplasty","volume":"23","author":"Tateishi","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib26","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/01.CIR.0000147611.92021.2B","article-title":"White HD for the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes","volume":"110","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ehj.2004.03.004","article-title":"Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC\/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes","volume":"25","author":"Bazzino","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/10976640701544589","article-title":"Relative role of Nt-pro BNP and cardiac troponin T at 96hours for estimation of infarction size and left ventricular function after acute myocardial infarction","volume":"9","author":"Steen","year":"2007","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib29","doi-asserted-by":"crossref","first-page":"83642","DOI":"10.1016\/j.nuclcard.2007.07.011","article-title":"N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left ventricular dysfunction in patients with stable coronary artery disease","volume":"14","author":"Vanzetto","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib30","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1161\/01.CIR.96.12.4204","article-title":"Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"96","author":"Toss","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0300-8932(02)76670-0","article-title":"Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-Q-wave myocardial infarction","volume":"55","author":"Arnau Vives","year":"2002","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2009.03.056","article-title":"Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome","volume":"54","author":"Eggers","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2008.115360","article-title":"C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian Aboriginal Cohort","volume":"55","author":"Shemesh","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/CDLI.10.4.652-657.2003","article-title":"Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood","volume":"10","author":"Aziz","year":"2003","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1373\/49.8.1258","article-title":"Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment","volume":"49","author":"Ledue","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1258\/acb.2007.007187","article-title":"Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system","volume":"45","author":"Cauliez","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1043-4666(02)91961-7","article-title":"Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum","volume":"19","author":"Kenis","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CDLI.6.1.89-95.1999","article-title":"Variables that affect assays for plasma cytokines and soluble activation markers","volume":"6","author":"Aziz","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10552-006-0035-5","article-title":"Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis","volume":"17","author":"Tworoger","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.atherosclerosis.2010.06.026_bib40","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/1055-9965.EPI-06-0629","article-title":"Collection, processing and storage of biological samples in epidemiological studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples","volume":"15","author":"Tworoger","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010004442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010004442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:19:19Z","timestamp":1591399159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010004442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0021915010004442"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.06.026","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}